LONLASSEO Trademark

Trademark Overview

On Friday, October 30, 2020, a trademark application was filed for LONLASSEO with the United States Patent and Trademark Office. The USPTO has given the LONLASSEO trademark a serial number of 90289415. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 8, 2024. This trademark is owned by Pfizer Inc.. The LONLASSEO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
lonlasseo

General Information

Serial Number90289415
Word MarkLONLASSEO
Filing DateFriday, October 30, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 26, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, November 3, 2020NEW APPLICATION ENTERED
Saturday, December 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 26, 2021ASSIGNED TO EXAMINER
Monday, March 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 6, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 21, 2021SOU TEAS EXTENSION RECEIVED
Thursday, October 21, 2021SOU EXTENSION 1 FILED
Thursday, October 21, 2021SOU EXTENSION 1 GRANTED
Saturday, October 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 28, 2022SOU TEAS EXTENSION RECEIVED
Thursday, April 28, 2022SOU EXTENSION 2 FILED
Thursday, April 28, 2022SOU EXTENSION 2 GRANTED
Saturday, April 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 28, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 28, 2022SOU EXTENSION 3 FILED
Friday, October 28, 2022SOU EXTENSION 3 GRANTED
Tuesday, November 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 26, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 26, 2023SOU EXTENSION 5 FILED
Wednesday, November 1, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 1, 2023SOU EXTENSION 5 GRANTED
Thursday, April 27, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 27, 2023SOU EXTENSION 4 FILED
Thursday, April 27, 2023SOU EXTENSION 4 GRANTED
Saturday, April 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023ASSIGNED TO EXAMINER
Monday, July 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, November 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

lonlasseo preparations disorders pharmaceutical treatment hypertension pain stroke cancer growth bone